The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 14, 2023

Filed:

Nov. 28, 2017
Applicant:

Biogen MA Inc., Cambridge, MA (US);

Inventors:

Sharon Tamir, Newton, MA (US);

Margaret Lee, Middleton, MA (US);

Marc De Ryck, Lier, BE;

Rafal M. Kaminski, Waterloo, BE;

Karine Leclercq, Gosselies, BE;

Benoit Kenda, Louvain La Neuve, BE;

Assignee:

BIOGEN MA INC., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4439 (2006.01); A61P 25/08 (2006.01); A61K 31/4196 (2006.01); A61K 31/497 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 31/4196 (2013.01); A61K 31/497 (2013.01); A61K 31/5377 (2013.01); A61P 25/08 (2018.01);
Abstract

The invention generally relates to the use of nuclear transport modulators, e.g., CRM1 inhibitors, of Formula (I) for treating epilepsy in a subject. Subjects can have unprovoked seizures without prior warning that affect one or both hemispheres of the brain. The disclosed methods can reduce the severity and occurrence of these unprovoked epileptic seizures and can result in resolution of epilepsy. The method comprises administering to the subject an effective amount of a compound represented by Formula (I) or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…